Bristol-Myers Squibb Company
Registered Principal Details
Business Or Interest:
Pharmacautical Manufacturer
Lobbying Interests:
All matters relating to health care and pharmaceutical manufacturing.
CEO Name:
Giovanni Caforio
Senior Director
Pharmacautical Manufacturer
Lobbying Interests:
All matters relating to health care and pharmaceutical manufacturing.
CEO Name:
Giovanni Caforio
Senior Director
Contact
HF
Helen Fitzpatrick
801 Pennsylvania Ave NW, Suite 325
Washington, DC 20004
(202) 783-8617
jmannion@skadden.com
http://www.bms.com
801 Pennsylvania Ave NW, Suite 325
Washington, DC 20004
(202) 783-8617
jmannion@skadden.com
http://www.bms.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Administrative Rulemaking Proceedings
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Agency Name
Office of the Commissioner of Insurance (Ins)
Subject
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Scope Statement
SS 123_19
1/29/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Office of the Commissioner of Insurance (Ins)
Subject
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Scope Statement
SS 123_19
None
Notification Date1/29/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Agency Name
Office of the Commissioner of Insurance (Ins)
Subject
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Scope Statement
SS 123_19
1/29/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Office of the Commissioner of Insurance (Ins)
Subject
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
Scope Statement
SS 123_19
None
Notification Date1/29/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $30,000.00 |
2019 July - December $22,440.00 |
2020 January - June $31,648.41 |
2020 July - December $30,000.00 |
Total $114,088.41 |
| Total Hours Communicating | 2019 January - June 0.00 |
2019 July - December 0.00 |
2020 January - June 3.00 |
2020 July - December 1.50 |
Total 4.50 |
| Total Hours Other | 2019 January - June 17.75 |
2019 July - December 92.50 |
2020 January - June 81.75 |
2020 July - December 41.25 |
Total 233.25 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
Step therapy protocols for prescription drug coverage, grievance procedure amendments and affecting small business
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June |
2019 July - December |
2020 January - June 7% |
2020 July - December 5% |
Total 3% |
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication